Zespół bólu mięśniowo-powięziowego
Epidemiologia
Zespół bólu mięśniowo-powięziowego (ZBMP) jest powszechnym schorzeniem mięśniowo-szkieletowym charakteryzującym się obecnością punktów spustowych w napiętych pasmach mięśni i powięzi, wywołujących ból miejscowy i przeniesiony. Epidemiologia ZBMP jest trudna do precyzyjnego określenia z powodu braku ujednoliconych kryteriów diagnostycznych, jednak szacuje się, że dotyka on od 30% do 93% pacjentów z bólami mięśniowo-szkieletowymi, a w populacji ogólnej aktywne punkty spustowe występują u około 46,1±27,4%. Najczęściej choroba dotyczy osób w wieku 27-50 lat, choć do 85% seniorów może cierpieć na ZBMP. Występuje zarówno u mężczyzn, jak i kobiet, z niektórymi badaniami wskazującymi na przewagę zachorowań u kobiet w stosunku 1,5:1 do 3:1. ZBMP jest jedną z najczęstszych przyczyn przewlekłego bólu regionalnego i stanowi istotne obciążenie dla systemów opieki zdrowotnej, generując koszty rzędu 47 miliardów dolarów rocznie w USA.
- Epidemiologia powięziowego” class=”to-tag” data-termid=”131294″>zespołu bólu mięśniowo-powięziowego
- Rozpowszechnienie w populacji ogólnej
- Występowanie w różnych grupach wiekowych
- Różnice płciowe w występowaniu ZBMP
- Występowanie w populacjach klinicznych
- Grupy wysokiego ryzyka
- Lokalizacja dolegliwości
- Czynniki ryzyka i współistniejące schorzenia
- Obciążenie ekonomiczne i społeczne
Epidemiologia powięziowego” class=”to-tag” data-termid=”131294″>zespołu bólu mięśniowo-powięziowego
Zespół bólu mięśniowo-powięziowego (ZBMP) to powszechnie występujące schorzenie mięśniowo-szkieletowe charakteryzujące się obecnością punktów spustowych w napiętych pasmach mięśni oraz powięzi, które wywołują zarówno ból miejscowy, jak i przeniesiony12. Mimo jego częstego występowania, precyzyjne dane epidemiologiczne są trudne do ustalenia, głównie z powodu braku ujednoliconych kryteriów diagnostycznych34.
Rozpowszechnienie w populacji ogólnej
Szacuje się, że zespół bólu mięśniowo-powięziowego dotyka od 30% do nawet 93% pacjentów z bólami mięśniowo-szkieletowymi56. W Stanach Zjednoczonych liczbę chorych szacuje się na około 9 milionów osób, z podobnym odsetkiem w Kanadzie78. Eksperci wskazują również, że aktywne punkty spustowe występują u około 46,1±27,4% populacji ogólnej9.
Według niektórych badań, nawet do 85% ogólnej populacji doświadczy tego schorzenia w jakimś momencie życia10. Osoby z przewlekłym bólem związanym z punktami spustowymi stanowią znaczący odsetek populacji, a zapadalność na to schorzenie wzrasta z roku na rok11.
Występowanie w różnych grupach wiekowych
Zespół bólu mięśniowo-powięziowego najczęściej występuje u osób w wieku od 27 do 50 lat1213, jednak może dotykać również pacjentów w innych grupach wiekowych. U osób młodszych schorzenie to występuje rzadziej, natomiast u osób w wieku średnim częstość występowania wzrasta, by następnie stopniowo się zmniejszać po przekroczeniu wieku średniego14.
Interesującym faktem jest to, że według jednego z kanadyjskich badań, do 85% seniorów cierpi na ZBMP15, co wskazuje na znaczne rozpowszechnienie tego schorzenia również w populacji osób starszych.
Różnice płciowe w występowaniu ZBMP
Kwestia różnic płciowych w zachorowalności na zespół bólu mięśniowo-powięziowego pozostaje niejasna16. Niektóre źródła wskazują, że ZBMP dotyka w równym stopniu mężczyzn i kobiety17, podczas gdy inne donoszą o przewadze występowania u kobiet18. W przypadku publikacji sugerujących większą częstość występowania u kobiet, stosunek zachorowalności waha się od 1,5:1 do 3:1 (kobiety:mężczyźni)19.
Występowanie w populacjach klinicznych
Zespół bólu mięśniowo-powięziowego jest jedną z najczęstszych przyczyn bólu mięśniowo-szkieletowego w praktyce klinicznej20. W zależności od rodzaju placówki medycznej, odsetek pacjentów z ZBMP waha się znacząco:
- W ogólnych klinikach ortopedycznych – około 21% pacjentów21
- W praktyce ogólnej medycyny wewnętrznej – około 10% wszystkich pacjentów i 31% pacjentów zgłaszających dolegliwości bólowe22
- W klinikach leczenia bólu – od 55% do 93% pacjentów232425
Zespół bólu mięśniowo-powięziowego jest najczęstszą przyczyną przewlekłego bólu regionalnego26 oraz najczęstszym rodzajem bólu, który skłania pacjentów do wizyty w ośrodkach leczenia bólu przewlekłego. W jednym z badań stwierdzono, że wśród 283 kolejnych przyjęć do kompleksowej kliniki leczenia bólu, 85% pacjentów otrzymało pierwotną organiczną diagnozę zespołu mięśniowo-powięziowego27.
Grupy wysokiego ryzyka
Zespół bólu mięśniowo-powięziowego częściej występuje w określonych grupach podwyższonego ryzyka, takich jak:
- Osoby prowadzące siedzący tryb życia2829
- Sportowcy3031
- Pracownicy wykonujący ciężkie prace fizyczne3233
- Osoby wykonujące powtarzalne czynności w pracy34
- Osoby pracujące w nieprawidłowych warunkach ergonomicznych35
- Osoby pracujące w środowiskach powodujących stres wizualny i posturalny36
Interesujące są również wyniki badania prospektywnego przeprowadzonego na grupie 116 kobiet po operacji raka piersi, które wykazało, że 52 z nich (44,8%, 95% CI: 35,6 do 54,3) rozwinęło zespół bólu mięśniowo-powięziowego w ciągu roku po zabiegu37.
Lokalizacja dolegliwości
Zespół bólu mięśniowo-powięziowego może występować w różnych częściach ciała, jednak najczęściej zajmuje następujące obszary:
Badanie przeprowadzone w Ameryce Południowej wykazało, że wśród pacjentów zgłaszających się na oddział ratunkowy z bólami głowy o charakterze nieurazowym, szyjny zespół bólu mięśniowo-powięziowego był najczęstszą przyczyną wtórną tych dolegliwości44.
Czynniki ryzyka i współistniejące schorzenia
Zidentyfikowano szereg czynników ryzyka związanych z rozwojem zespołu bólu mięśniowo-powięziowego. Badania wykazują, że bezsenność stanowi istotny czynnik ryzyka. W populacyjnym badaniu podłużnym z 10-letnim okresem obserwacji, pacjenci z bezsennością byli 1,93 razy bardziej narażeni na rozwój ZBMP niż pacjenci z grupy kontrolnej, po uwzględnieniu wieku, płci, miesięcznego dochodu, urbanizacji i chorób współistniejących45.
Zespół bólu mięśniowo-powięziowego często współistnieje z innymi zaburzeniami nerwowo-mięśniowo-szkieletowymi lub ogólnoustrojowymi46. Choć ZBMP i fibromialgia są definiowane jako odrębne jednostki chorobowe, mogą one współistnieć lub znacznie się pokrywać4748. U niektórych pacjentów regionalnie zlokalizowany ZBMP może ewoluować w kierunku fibromialgii49.
Obciążenie ekonomiczne i społeczne
Zespół bólu mięśniowo-powięziowego stanowi znaczące obciążenie ekonomiczne dla systemów opieki zdrowotnej. Szacuje się, że koszty związane z ZBMP w Stanach Zjednoczonych wynoszą około 47 miliardów dolarów rocznie50. Wyraźna rozbieżność między szacowanym rozpowszechnieniem i obciążeniem związanym z ZBMP a długością tekstów na jego temat w powszechnych podręcznikach medycznych odzwierciedla brak zrozumienia tej jednostki chorobowej5152.
Monitoring i nadzór nad ZBMP
Zespół bólu mięśniowo-powięziowego jest chorobą, dla której nie opracowano standardowego protokołu postępowania i nadzoru53. Brak konsensusu dotyczącego definicji, kryteriów diagnostycznych i klasyfikacji ZBMP komplikuje opracowanie standaryzowanych protokołów leczenia54.
Aktualnie prowadzone są badania epidemiologiczne w głównych rynkach medycznych, obejmujących Stany Zjednoczone, kraje UE5 (Niemcy, Hiszpania, Włochy, Francja i Wielka Brytania) oraz Japonię555657. Według tych danych, Stany Zjednoczone mają największą pulę pacjentów z zespołem bólu mięśniowo-powięziowego i reprezentują największy rynek dla jego leczenia5859.
Badania kliniczne i rozwój wiedzy
W bazie ClinicalTrials.gov zarejestrowano co najmniej 878 badań klinicznych związanych z zespołem bólu mięśniowo-powięziowego, w tym 21 aktywnych, 578 zakończonych i 92 rekrutujących pacjentów60. Publikacje naukowe dotyczące punktów spustowych mięśniowo-powięziowych znacząco wzrosły w ciągu ostatniej dekady61, co wskazuje na rosnące zainteresowanie tą jednostką chorobową w środowisku naukowym.
Mimo to, ZBMP pozostaje schorzeniem niedostatecznie rozpoznawanym i często pomijanym w diagnostyce różnicowej, głównie ze względu na nakładanie się objawów z innymi zaburzeniami bólowymi, takimi jak fibromialgia, ból neuropatyczny czy zaburzenia stawowe62. W Meksyku, mimo wysokiego rozpowszechnienia, jest to choroba niedostatecznie diagnozowana63.
Zespół bólu mięśniowo-powięziowego jest słabo zbadanym schorzeniem64, a jego patogeneza, kryteria diagnostyczne i klasyfikacja są nadal przedmiotem badań65. Konieczne są randomizowane badania, które umożliwią lepsze zrozumienie i wykrywanie różnych czynników zaangażowanych w powstawanie punktów spustowych66.
Wyzwania w badaniach epidemiologicznych
Główne wyzwania w badaniach epidemiologicznych zespołu bólu mięśniowo-powięziowego obejmują:
- Brak standardowych kryteriów diagnostycznych6768
- Brak konsensusu co do definicji choroby6970
- Brak jasno określonej patofizjologii71
- Nakładanie się objawów z innymi jednostkami chorobowymi72
- Brak specyficznych wskaźników laboratoryjnych i dowodów obrazowych73
Te czynniki sprawiają, że precyzyjne określenie rozpowszechnienia zespołu bólu mięśniowo-powięziowego w populacji ogólnej jest trudne, a choroba ta pozostaje jedną z najczęściej niedodiagnozowanych, niedoleczonych i niezrozumiałych przyczyn wszechobecnych bólów ludzkości7475.
Kolejne rozdziały
Zapraszamy do dalszego czytania naszego leksykonu.
Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.
Materiały źródłowe
- #1 Expert consensus on the diagnosis and treatment of myofascial pain syndromehttps://www.wjgnet.com/2307-8960/full/v9/i9/2077.htm
Myofascial pain syndrome (MPS) is characterized by myofascial trigger points and fascial constrictions. […] At present, domestic and foreign scholars have not reached a consensus on the etiology and pathogenesis of MPS. […] Due to the lack of specific laboratory indicators and imaging evidence, there is no unified diagnostic criteria for MPS, making it easy to confuse with other diseases. […] MPS is a common disease that can be seen at any age, though mostly in elderly adults, athletes, hard physical laborers and sedentary workers. […] About 30.0% to 93.0% of patients with musculoskeletal pain suffer from MPS. […] About 46.1% of the patients reveal active MTrP in the physical examinations. […] Clinical studies have shown that at least 40.0% of skeletal muscle pain syndrome is mainly because of the activated trigger points in painful muscles.
- #2 Myofascial Pain Syndrome. Epidemiology, Pathophysiology, Diagnosis and Treatmenthttps://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=43909
Myofascial pain syndrome is defined by the presence of myofascial trigger points in a palpable taut band that produces pain and tenderness in the muscle or its fascia. […] In Mexico it is an underdiagnosed disease despite has a high prevalence. This paper reviews the epidemiology, pathophysiology, diagnosis and treatment of myofascial pain syndrome.
- #3https://europepmc.org/books/n/statpearls/article-25476/?extid=29261915&src=med
The exact prevalence of myofascial pain syndrome in the general population is rarely mentioned in the existing literature, likely due to the lack of standardized diagnostic criteria. Sources claim that myofascial pain syndrome affects from 30% to 93% of patients seeking care for musculoskeletal pain. Although typically found in the population aged from 27 to 50, the disorder can also affect older and high-risk populations, such as those with sedentary lifestyles, athletes, or workers who have physically demanding jobs. The most frequently affected areas include the neck, shoulders, and back. The gender difference in the incidence of myofascial pain syndrome remains unclear.
- #4 Myofascial Pain | PM&R KnowledgeNowhttps://now.aapmr.org/myofascial-pain/
Myofascial pain is a purely clinical diagnosis and lacks objective and systematic diagnostic criteria. This lack of consensus-driven, reliable diagnostic criteria makes it difficult to establish accurate statistics about incidence and prevalence. Approximately 9 million people in the United States are thought to suffer from myofascial pain. MPS affects up to 95% of patients with chronic pain, and in one study, MPS was found to be the primary cause of pain in 85% of patients attending a large pain center. […] Occupational risk factors for development of MPS include repetitive work activities, sub-optimal ergonomics, and work environments that result in both visual and postural stress.
- #5https://europepmc.org/books/n/statpearls/article-25476/?extid=29261915&src=med
The exact prevalence of myofascial pain syndrome in the general population is rarely mentioned in the existing literature, likely due to the lack of standardized diagnostic criteria. Sources claim that myofascial pain syndrome affects from 30% to 93% of patients seeking care for musculoskeletal pain. Although typically found in the population aged from 27 to 50, the disorder can also affect older and high-risk populations, such as those with sedentary lifestyles, athletes, or workers who have physically demanding jobs. The most frequently affected areas include the neck, shoulders, and back. The gender difference in the incidence of myofascial pain syndrome remains unclear.
- #6 Expert consensus on the diagnosis and treatment of myofascial pain syndromehttps://www.wjgnet.com/2307-8960/full/v9/i9/2077.htm
Myofascial pain syndrome (MPS) is characterized by myofascial trigger points and fascial constrictions. […] At present, domestic and foreign scholars have not reached a consensus on the etiology and pathogenesis of MPS. […] Due to the lack of specific laboratory indicators and imaging evidence, there is no unified diagnostic criteria for MPS, making it easy to confuse with other diseases. […] MPS is a common disease that can be seen at any age, though mostly in elderly adults, athletes, hard physical laborers and sedentary workers. […] About 30.0% to 93.0% of patients with musculoskeletal pain suffer from MPS. […] About 46.1% of the patients reveal active MTrP in the physical examinations. […] Clinical studies have shown that at least 40.0% of skeletal muscle pain syndrome is mainly because of the activated trigger points in painful muscles.
- #7 Myofascial Pain – StatPearls – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/NBK535344/
The prevalence of myofascial pain syndrome in the United States is about 9 million, and it is estimated that the same percentage of patients is found in Canada. Myofascial pain syndrome affects men and women equally, while it is more prevalent in people greater than 60 years of age. There is no convincing data to suggest a relationship between myofascial pain and ethnicity or geographical location.[13] […] Myofascial pain syndrome is a disease with no standard management and surveillance protocol. […] Multiple TPs persistent for not less than a year confirms myofascial pain syndrome.[7]
- #8 Myofascial Pain | PM&R KnowledgeNowhttps://now.aapmr.org/myofascial-pain/
Myofascial pain is a purely clinical diagnosis and lacks objective and systematic diagnostic criteria. This lack of consensus-driven, reliable diagnostic criteria makes it difficult to establish accurate statistics about incidence and prevalence. Approximately 9 million people in the United States are thought to suffer from myofascial pain. MPS affects up to 95% of patients with chronic pain, and in one study, MPS was found to be the primary cause of pain in 85% of patients attending a large pain center. […] Occupational risk factors for development of MPS include repetitive work activities, sub-optimal ergonomics, and work environments that result in both visual and postural stress.
- #9 Discrepancy between prevalence and perceived effectiveness of treatment methods in myofascial pain syndrome: Results of a cross-sectional, nationwide survey | BMC Musculoskeletal Disorders | Full Texthttps://bmcmusculoskeletdisord.biomedcentral.com/articles/10.1186/1471-2474-11-32
Myofascial pain is a common dysfunction with a lifetime prevalence affecting up to 85% of the general population. […] Myofascial pain affects up to 85% of the general population. […] Myofascial pain was estimated a prevalent condition. […] The estimated overall prevalence of active myofascial trigger points is 46.1 27.4%. […] Physicians estimated the prevalence of active trigger points to 46.1 27.4% (n = 329) in the overall population and 52.8% 26.9 (n = 330) in their own patients. […] The majority of physicians, even whilst prescribing, characterized the available symptomatic treatment options as insufficient. […] Myofascial trigger points have been described as a 'common cause of pain in clinical practice’ and an 'extremely common, yet commonly overlooked’ source of musculoskeletal disorders.
- #10 Myofascial Pain Syndrome: What It Is, Symptoms & Treatmenthttps://my.clevelandclinic.org/health/diseases/12054-myofascial-pain-syndrome
Myofascial pain syndrome is common. Experts estimate that up to 85% of the general population will develop the condition at some point. […] Myofascial pain syndrome is often underdiagnosed and overlooked. This is because many of its symptoms overlap with other conditions that affect your nerves, bones, ligaments or tendons. […] To diagnose myofascial pain syndrome, your healthcare provider will need to physically examine your muscles to feel for taut bands of muscles and then find the tender spots. Finding and applying pressure to a trigger point will result in pain, felt at the immediate spot or in an area a short distance away (referred pain). […] You cant always prevent myofascial pain syndrome. But there are certain things you can do to reduce your risk: Maintain proper sleep hygiene. Reduce your stress. Get exercise.
- #11 Expert consensus on the diagnosis and treatment of myofascial pain syndromehttps://www.wjgnet.com/2307-8960/full/v9/i9/2077.htm
The predilection sites of MPS are the neck, shoulders and back. […] At present, the prevalence rate of chronic pain induced by trigger points is increasing annually. […] The patients suffering from MPS present as persistent pain, and the range of physical motion always decreases with the age increase.
- #12https://europepmc.org/books/n/statpearls/article-25476/?extid=29261915&src=med
The exact prevalence of myofascial pain syndrome in the general population is rarely mentioned in the existing literature, likely due to the lack of standardized diagnostic criteria. Sources claim that myofascial pain syndrome affects from 30% to 93% of patients seeking care for musculoskeletal pain. Although typically found in the population aged from 27 to 50, the disorder can also affect older and high-risk populations, such as those with sedentary lifestyles, athletes, or workers who have physically demanding jobs. The most frequently affected areas include the neck, shoulders, and back. The gender difference in the incidence of myofascial pain syndrome remains unclear.
- #13 Myofascial Pain Syndrome – Illinois Chiropractic Societyhttps://ilchiro.org/myofascial-pain-syndrome/
Myofascial pain syndrome affects all ages, races, and genders. (2,13,18) MPS is thought to be the most common cause of musculoskeletal pain, affecting between 30-93% of symptomatic musculoskeletal patients. (19-22) Various authors have suggested that peak prevalence occurs between ages 27 -50. (23,24) However, one Canadian study found that up to 85% of seniors suffer from MPS. (25) […] Myofascial pain syndrome is the most common cause of chronic regional pain. (3) […] Myofascial pain syndrome frequently coexists with various other neuromusculoskeletal or systemic disorders. (4)
- #14 Cervical Myofascial Pain: Practice Essentials, Etiology, Epidemiologyhttps://emedicine.medscape.com/article/305937-overview
Myofascial pain is thought to occur commonly in the general population. As many as 21% of patients seen in general orthopedic clinics have myofascial pain. Of patients seen at specialty pain management centers, 85-93% have a myofascial pain component to their condition. […] A South American study by Munoz-Ceron et al reported that of emergency department patients with nontraumatic headaches, cervical myofascial pain was the most frequent nonprimary cause. […] Cervical myofascial pain occurs in both sexes but with a predominance among women. Myofascial pain seems to occur more frequently with increasing age until midlife. The incidence declines gradually after middle age.
- #15 Myofascial Pain Syndrome – Illinois Chiropractic Societyhttps://ilchiro.org/myofascial-pain-syndrome/
Myofascial pain syndrome affects all ages, races, and genders. (2,13,18) MPS is thought to be the most common cause of musculoskeletal pain, affecting between 30-93% of symptomatic musculoskeletal patients. (19-22) Various authors have suggested that peak prevalence occurs between ages 27 -50. (23,24) However, one Canadian study found that up to 85% of seniors suffer from MPS. (25) […] Myofascial pain syndrome is the most common cause of chronic regional pain. (3) […] Myofascial pain syndrome frequently coexists with various other neuromusculoskeletal or systemic disorders. (4)
- #16https://europepmc.org/books/n/statpearls/article-25476/?extid=29261915&src=med
The exact prevalence of myofascial pain syndrome in the general population is rarely mentioned in the existing literature, likely due to the lack of standardized diagnostic criteria. Sources claim that myofascial pain syndrome affects from 30% to 93% of patients seeking care for musculoskeletal pain. Although typically found in the population aged from 27 to 50, the disorder can also affect older and high-risk populations, such as those with sedentary lifestyles, athletes, or workers who have physically demanding jobs. The most frequently affected areas include the neck, shoulders, and back. The gender difference in the incidence of myofascial pain syndrome remains unclear.
- #17 Myofascial Pain – StatPearls – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/NBK535344/
The prevalence of myofascial pain syndrome in the United States is about 9 million, and it is estimated that the same percentage of patients is found in Canada. Myofascial pain syndrome affects men and women equally, while it is more prevalent in people greater than 60 years of age. There is no convincing data to suggest a relationship between myofascial pain and ethnicity or geographical location.[13] […] Myofascial pain syndrome is a disease with no standard management and surveillance protocol. […] Multiple TPs persistent for not less than a year confirms myofascial pain syndrome.[7]
- #18 Cervical Myofascial Pain: Practice Essentials, Etiology, Epidemiologyhttps://emedicine.medscape.com/article/305937-overview
Myofascial pain is thought to occur commonly in the general population. As many as 21% of patients seen in general orthopedic clinics have myofascial pain. Of patients seen at specialty pain management centers, 85-93% have a myofascial pain component to their condition. […] A South American study by Munoz-Ceron et al reported that of emergency department patients with nontraumatic headaches, cervical myofascial pain was the most frequent nonprimary cause. […] Cervical myofascial pain occurs in both sexes but with a predominance among women. Myofascial pain seems to occur more frequently with increasing age until midlife. The incidence declines gradually after middle age.
- #19 Myofascial pain syndrome | MedLink Neurologyhttps://www.medlink.com/articles/myofascial-pain-syndrome
Few controlled studies have been published on the prevalence of this condition. There appears to be a female predominance, with estimates varying between 1.5:1 and 3:1. […] Numerous anecdotal reports suggest that myofascial pain is commonly a result of musculoskeletal injury, particularly in industry, where it is a frequent cause of disability after trauma, and in motor vehicle accidents, where it is seen as a major component of the whiplash syndrome. […] Torres and colleagues conducted a 1-year prospective follow-up after breast cancer surgery, which included 116 women. Fifty-two women out of 116 total subjects developed myofascial pain syndrome after breast cancer surgery (44.8%, 95% CI: 35.6 to 54.3). […] Insomnia is a risk factor for myofascial pain syndrome. In a population-based longitudinal study with 10-year follow-up, the insomnia patients were 1.93 times more likely to develop myofascial pain syndrome than the control patients after adjusting for age, sex, monthly income, urbanization, and comorbidities.
- #20 Myofascial Pain Syndrome – Illinois Chiropractic Societyhttps://ilchiro.org/myofascial-pain-syndrome/
Myofascial pain syndrome affects all ages, races, and genders. (2,13,18) MPS is thought to be the most common cause of musculoskeletal pain, affecting between 30-93% of symptomatic musculoskeletal patients. (19-22) Various authors have suggested that peak prevalence occurs between ages 27 -50. (23,24) However, one Canadian study found that up to 85% of seniors suffer from MPS. (25) […] Myofascial pain syndrome is the most common cause of chronic regional pain. (3) […] Myofascial pain syndrome frequently coexists with various other neuromusculoskeletal or systemic disorders. (4)
- #21 Cervical Myofascial Pain: Practice Essentials, Etiology, Epidemiologyhttps://emedicine.medscape.com/article/305937-overview
Myofascial pain is thought to occur commonly in the general population. As many as 21% of patients seen in general orthopedic clinics have myofascial pain. Of patients seen at specialty pain management centers, 85-93% have a myofascial pain component to their condition. […] A South American study by Munoz-Ceron et al reported that of emergency department patients with nontraumatic headaches, cervical myofascial pain was the most frequent nonprimary cause. […] Cervical myofascial pain occurs in both sexes but with a predominance among women. Myofascial pain seems to occur more frequently with increasing age until midlife. The incidence declines gradually after middle age.
- #22 Myofascial pain syndrome | MedLink Neurologyhttps://www.medlink.com/articles/myofascial-pain-syndrome
Myofascial pain syndrome affects 10% of patients in internal medicine practice and 55% to 85% of those attending pain clinics. […] Myofascial pain syndrome is the most common type of pain that brings patients to chronic pain treatment centers. Among 283 consecutive admissions to a comprehensive pain clinic, 85% were assigned a primary organic diagnosis of myofascial syndrome. […] Among 296 patients referred to a dental clinic for chronic head and neck pain of at least 6 months’ duration, the primary diagnosis was myofascial pain in 55.4% of cases. […] Acute myofascial pain is also common in general medical practice. Among 61 consecutive consultation or follow-up patients in an internal medicine group practice, 10% of all patients and 31% of those presenting with a pain complaint had myofascial trigger points identified as being primarily responsible for their symptoms.
- #23 Myofascial pain syndrome | MedLink Neurologyhttps://www.medlink.com/articles/myofascial-pain-syndrome
Myofascial pain syndrome affects 10% of patients in internal medicine practice and 55% to 85% of those attending pain clinics. […] Myofascial pain syndrome is the most common type of pain that brings patients to chronic pain treatment centers. Among 283 consecutive admissions to a comprehensive pain clinic, 85% were assigned a primary organic diagnosis of myofascial syndrome. […] Among 296 patients referred to a dental clinic for chronic head and neck pain of at least 6 months’ duration, the primary diagnosis was myofascial pain in 55.4% of cases. […] Acute myofascial pain is also common in general medical practice. Among 61 consecutive consultation or follow-up patients in an internal medicine group practice, 10% of all patients and 31% of those presenting with a pain complaint had myofascial trigger points identified as being primarily responsible for their symptoms.
- #24 Myofascial Pain | PM&R KnowledgeNowhttps://now.aapmr.org/myofascial-pain/
Myofascial pain is a purely clinical diagnosis and lacks objective and systematic diagnostic criteria. This lack of consensus-driven, reliable diagnostic criteria makes it difficult to establish accurate statistics about incidence and prevalence. Approximately 9 million people in the United States are thought to suffer from myofascial pain. MPS affects up to 95% of patients with chronic pain, and in one study, MPS was found to be the primary cause of pain in 85% of patients attending a large pain center. […] Occupational risk factors for development of MPS include repetitive work activities, sub-optimal ergonomics, and work environments that result in both visual and postural stress.
- #25 Myofascial Pain Syndrome and Trigger-Point Management | Regional Anesthesia & Pain Medicinehttps://rapm.bmj.com/content/22/1/89
Myofascial pain syndrome (MPS) is a common condition often resulting in referral to a pain clinic. The incidence of MPS with associated trigger points appears to vary between 30 and 85% of people presenting to pain clinics, and the condition is more prevalent in women than in men. Patients complain of regional persistent pain, ranging in intensity and most frequently found in the head, neck, shoulders, extremities, and low back. […] A multidisciplinary approach to treatment appears to be most beneficial and may include such modalities as trigger-point injections, dry needling, stretch and spray, and transcutaneous electrical nerve stimulation. […] The definitive pathogenesis of MPS is currently unknown, and no single diagnostic method is consistently positive.
- #26 Myofascial Pain Syndrome – Illinois Chiropractic Societyhttps://ilchiro.org/myofascial-pain-syndrome/
Myofascial pain syndrome affects all ages, races, and genders. (2,13,18) MPS is thought to be the most common cause of musculoskeletal pain, affecting between 30-93% of symptomatic musculoskeletal patients. (19-22) Various authors have suggested that peak prevalence occurs between ages 27 -50. (23,24) However, one Canadian study found that up to 85% of seniors suffer from MPS. (25) […] Myofascial pain syndrome is the most common cause of chronic regional pain. (3) […] Myofascial pain syndrome frequently coexists with various other neuromusculoskeletal or systemic disorders. (4)
- #27 Myofascial pain syndrome | MedLink Neurologyhttps://www.medlink.com/articles/myofascial-pain-syndrome
Myofascial pain syndrome affects 10% of patients in internal medicine practice and 55% to 85% of those attending pain clinics. […] Myofascial pain syndrome is the most common type of pain that brings patients to chronic pain treatment centers. Among 283 consecutive admissions to a comprehensive pain clinic, 85% were assigned a primary organic diagnosis of myofascial syndrome. […] Among 296 patients referred to a dental clinic for chronic head and neck pain of at least 6 months’ duration, the primary diagnosis was myofascial pain in 55.4% of cases. […] Acute myofascial pain is also common in general medical practice. Among 61 consecutive consultation or follow-up patients in an internal medicine group practice, 10% of all patients and 31% of those presenting with a pain complaint had myofascial trigger points identified as being primarily responsible for their symptoms.
- #28https://europepmc.org/books/n/statpearls/article-25476/?extid=29261915&src=med
The exact prevalence of myofascial pain syndrome in the general population is rarely mentioned in the existing literature, likely due to the lack of standardized diagnostic criteria. Sources claim that myofascial pain syndrome affects from 30% to 93% of patients seeking care for musculoskeletal pain. Although typically found in the population aged from 27 to 50, the disorder can also affect older and high-risk populations, such as those with sedentary lifestyles, athletes, or workers who have physically demanding jobs. The most frequently affected areas include the neck, shoulders, and back. The gender difference in the incidence of myofascial pain syndrome remains unclear.
- #29 Expert consensus on the diagnosis and treatment of myofascial pain syndromehttps://www.wjgnet.com/2307-8960/full/v9/i9/2077.htm
Myofascial pain syndrome (MPS) is characterized by myofascial trigger points and fascial constrictions. […] At present, domestic and foreign scholars have not reached a consensus on the etiology and pathogenesis of MPS. […] Due to the lack of specific laboratory indicators and imaging evidence, there is no unified diagnostic criteria for MPS, making it easy to confuse with other diseases. […] MPS is a common disease that can be seen at any age, though mostly in elderly adults, athletes, hard physical laborers and sedentary workers. […] About 30.0% to 93.0% of patients with musculoskeletal pain suffer from MPS. […] About 46.1% of the patients reveal active MTrP in the physical examinations. […] Clinical studies have shown that at least 40.0% of skeletal muscle pain syndrome is mainly because of the activated trigger points in painful muscles.
- #30https://europepmc.org/books/n/statpearls/article-25476/?extid=29261915&src=med
The exact prevalence of myofascial pain syndrome in the general population is rarely mentioned in the existing literature, likely due to the lack of standardized diagnostic criteria. Sources claim that myofascial pain syndrome affects from 30% to 93% of patients seeking care for musculoskeletal pain. Although typically found in the population aged from 27 to 50, the disorder can also affect older and high-risk populations, such as those with sedentary lifestyles, athletes, or workers who have physically demanding jobs. The most frequently affected areas include the neck, shoulders, and back. The gender difference in the incidence of myofascial pain syndrome remains unclear.
- #31 Expert consensus on the diagnosis and treatment of myofascial pain syndromehttps://www.wjgnet.com/2307-8960/full/v9/i9/2077.htm
Myofascial pain syndrome (MPS) is characterized by myofascial trigger points and fascial constrictions. […] At present, domestic and foreign scholars have not reached a consensus on the etiology and pathogenesis of MPS. […] Due to the lack of specific laboratory indicators and imaging evidence, there is no unified diagnostic criteria for MPS, making it easy to confuse with other diseases. […] MPS is a common disease that can be seen at any age, though mostly in elderly adults, athletes, hard physical laborers and sedentary workers. […] About 30.0% to 93.0% of patients with musculoskeletal pain suffer from MPS. […] About 46.1% of the patients reveal active MTrP in the physical examinations. […] Clinical studies have shown that at least 40.0% of skeletal muscle pain syndrome is mainly because of the activated trigger points in painful muscles.
- #32https://europepmc.org/books/n/statpearls/article-25476/?extid=29261915&src=med
The exact prevalence of myofascial pain syndrome in the general population is rarely mentioned in the existing literature, likely due to the lack of standardized diagnostic criteria. Sources claim that myofascial pain syndrome affects from 30% to 93% of patients seeking care for musculoskeletal pain. Although typically found in the population aged from 27 to 50, the disorder can also affect older and high-risk populations, such as those with sedentary lifestyles, athletes, or workers who have physically demanding jobs. The most frequently affected areas include the neck, shoulders, and back. The gender difference in the incidence of myofascial pain syndrome remains unclear.
- #33 Expert consensus on the diagnosis and treatment of myofascial pain syndromehttps://www.wjgnet.com/2307-8960/full/v9/i9/2077.htm
Myofascial pain syndrome (MPS) is characterized by myofascial trigger points and fascial constrictions. […] At present, domestic and foreign scholars have not reached a consensus on the etiology and pathogenesis of MPS. […] Due to the lack of specific laboratory indicators and imaging evidence, there is no unified diagnostic criteria for MPS, making it easy to confuse with other diseases. […] MPS is a common disease that can be seen at any age, though mostly in elderly adults, athletes, hard physical laborers and sedentary workers. […] About 30.0% to 93.0% of patients with musculoskeletal pain suffer from MPS. […] About 46.1% of the patients reveal active MTrP in the physical examinations. […] Clinical studies have shown that at least 40.0% of skeletal muscle pain syndrome is mainly because of the activated trigger points in painful muscles.
- #34 Myofascial Pain | PM&R KnowledgeNowhttps://now.aapmr.org/myofascial-pain/
Myofascial pain is a purely clinical diagnosis and lacks objective and systematic diagnostic criteria. This lack of consensus-driven, reliable diagnostic criteria makes it difficult to establish accurate statistics about incidence and prevalence. Approximately 9 million people in the United States are thought to suffer from myofascial pain. MPS affects up to 95% of patients with chronic pain, and in one study, MPS was found to be the primary cause of pain in 85% of patients attending a large pain center. […] Occupational risk factors for development of MPS include repetitive work activities, sub-optimal ergonomics, and work environments that result in both visual and postural stress.
- #35 Myofascial Pain | PM&R KnowledgeNowhttps://now.aapmr.org/myofascial-pain/
Myofascial pain is a purely clinical diagnosis and lacks objective and systematic diagnostic criteria. This lack of consensus-driven, reliable diagnostic criteria makes it difficult to establish accurate statistics about incidence and prevalence. Approximately 9 million people in the United States are thought to suffer from myofascial pain. MPS affects up to 95% of patients with chronic pain, and in one study, MPS was found to be the primary cause of pain in 85% of patients attending a large pain center. […] Occupational risk factors for development of MPS include repetitive work activities, sub-optimal ergonomics, and work environments that result in both visual and postural stress.
- #36 Myofascial Pain | PM&R KnowledgeNowhttps://now.aapmr.org/myofascial-pain/
Myofascial pain is a purely clinical diagnosis and lacks objective and systematic diagnostic criteria. This lack of consensus-driven, reliable diagnostic criteria makes it difficult to establish accurate statistics about incidence and prevalence. Approximately 9 million people in the United States are thought to suffer from myofascial pain. MPS affects up to 95% of patients with chronic pain, and in one study, MPS was found to be the primary cause of pain in 85% of patients attending a large pain center. […] Occupational risk factors for development of MPS include repetitive work activities, sub-optimal ergonomics, and work environments that result in both visual and postural stress.
- #37 Myofascial pain syndrome | MedLink Neurologyhttps://www.medlink.com/articles/myofascial-pain-syndrome
Few controlled studies have been published on the prevalence of this condition. There appears to be a female predominance, with estimates varying between 1.5:1 and 3:1. […] Numerous anecdotal reports suggest that myofascial pain is commonly a result of musculoskeletal injury, particularly in industry, where it is a frequent cause of disability after trauma, and in motor vehicle accidents, where it is seen as a major component of the whiplash syndrome. […] Torres and colleagues conducted a 1-year prospective follow-up after breast cancer surgery, which included 116 women. Fifty-two women out of 116 total subjects developed myofascial pain syndrome after breast cancer surgery (44.8%, 95% CI: 35.6 to 54.3). […] Insomnia is a risk factor for myofascial pain syndrome. In a population-based longitudinal study with 10-year follow-up, the insomnia patients were 1.93 times more likely to develop myofascial pain syndrome than the control patients after adjusting for age, sex, monthly income, urbanization, and comorbidities.
- #38https://europepmc.org/books/n/statpearls/article-25476/?extid=29261915&src=med
The exact prevalence of myofascial pain syndrome in the general population is rarely mentioned in the existing literature, likely due to the lack of standardized diagnostic criteria. Sources claim that myofascial pain syndrome affects from 30% to 93% of patients seeking care for musculoskeletal pain. Although typically found in the population aged from 27 to 50, the disorder can also affect older and high-risk populations, such as those with sedentary lifestyles, athletes, or workers who have physically demanding jobs. The most frequently affected areas include the neck, shoulders, and back. The gender difference in the incidence of myofascial pain syndrome remains unclear.
- #39 Expert consensus on the diagnosis and treatment of myofascial pain syndromehttps://www.wjgnet.com/2307-8960/full/v9/i9/2077.htm
The predilection sites of MPS are the neck, shoulders and back. […] At present, the prevalence rate of chronic pain induced by trigger points is increasing annually. […] The patients suffering from MPS present as persistent pain, and the range of physical motion always decreases with the age increase.
- #40https://europepmc.org/books/n/statpearls/article-25476/?extid=29261915&src=med
The exact prevalence of myofascial pain syndrome in the general population is rarely mentioned in the existing literature, likely due to the lack of standardized diagnostic criteria. Sources claim that myofascial pain syndrome affects from 30% to 93% of patients seeking care for musculoskeletal pain. Although typically found in the population aged from 27 to 50, the disorder can also affect older and high-risk populations, such as those with sedentary lifestyles, athletes, or workers who have physically demanding jobs. The most frequently affected areas include the neck, shoulders, and back. The gender difference in the incidence of myofascial pain syndrome remains unclear.
- #41 Expert consensus on the diagnosis and treatment of myofascial pain syndromehttps://www.wjgnet.com/2307-8960/full/v9/i9/2077.htm
The predilection sites of MPS are the neck, shoulders and back. […] At present, the prevalence rate of chronic pain induced by trigger points is increasing annually. […] The patients suffering from MPS present as persistent pain, and the range of physical motion always decreases with the age increase.
- #42https://europepmc.org/books/n/statpearls/article-25476/?extid=29261915&src=med
The exact prevalence of myofascial pain syndrome in the general population is rarely mentioned in the existing literature, likely due to the lack of standardized diagnostic criteria. Sources claim that myofascial pain syndrome affects from 30% to 93% of patients seeking care for musculoskeletal pain. Although typically found in the population aged from 27 to 50, the disorder can also affect older and high-risk populations, such as those with sedentary lifestyles, athletes, or workers who have physically demanding jobs. The most frequently affected areas include the neck, shoulders, and back. The gender difference in the incidence of myofascial pain syndrome remains unclear.
- #43 Expert consensus on the diagnosis and treatment of myofascial pain syndromehttps://www.wjgnet.com/2307-8960/full/v9/i9/2077.htm
The predilection sites of MPS are the neck, shoulders and back. […] At present, the prevalence rate of chronic pain induced by trigger points is increasing annually. […] The patients suffering from MPS present as persistent pain, and the range of physical motion always decreases with the age increase.
- #44 Cervical Myofascial Pain: Practice Essentials, Etiology, Epidemiologyhttps://emedicine.medscape.com/article/305937-overview
Myofascial pain is thought to occur commonly in the general population. As many as 21% of patients seen in general orthopedic clinics have myofascial pain. Of patients seen at specialty pain management centers, 85-93% have a myofascial pain component to their condition. […] A South American study by Munoz-Ceron et al reported that of emergency department patients with nontraumatic headaches, cervical myofascial pain was the most frequent nonprimary cause. […] Cervical myofascial pain occurs in both sexes but with a predominance among women. Myofascial pain seems to occur more frequently with increasing age until midlife. The incidence declines gradually after middle age.
- #45 Myofascial pain syndrome | MedLink Neurologyhttps://www.medlink.com/articles/myofascial-pain-syndrome
Few controlled studies have been published on the prevalence of this condition. There appears to be a female predominance, with estimates varying between 1.5:1 and 3:1. […] Numerous anecdotal reports suggest that myofascial pain is commonly a result of musculoskeletal injury, particularly in industry, where it is a frequent cause of disability after trauma, and in motor vehicle accidents, where it is seen as a major component of the whiplash syndrome. […] Torres and colleagues conducted a 1-year prospective follow-up after breast cancer surgery, which included 116 women. Fifty-two women out of 116 total subjects developed myofascial pain syndrome after breast cancer surgery (44.8%, 95% CI: 35.6 to 54.3). […] Insomnia is a risk factor for myofascial pain syndrome. In a population-based longitudinal study with 10-year follow-up, the insomnia patients were 1.93 times more likely to develop myofascial pain syndrome than the control patients after adjusting for age, sex, monthly income, urbanization, and comorbidities.
- #46 Myofascial Pain Syndrome – Illinois Chiropractic Societyhttps://ilchiro.org/myofascial-pain-syndrome/
Myofascial pain syndrome affects all ages, races, and genders. (2,13,18) MPS is thought to be the most common cause of musculoskeletal pain, affecting between 30-93% of symptomatic musculoskeletal patients. (19-22) Various authors have suggested that peak prevalence occurs between ages 27 -50. (23,24) However, one Canadian study found that up to 85% of seniors suffer from MPS. (25) […] Myofascial pain syndrome is the most common cause of chronic regional pain. (3) […] Myofascial pain syndrome frequently coexists with various other neuromusculoskeletal or systemic disorders. (4)
- #47 Scoping review and interpretation of myofascial pain/fibromyalgia syndrome: An attempt to assemble a medical puzzle | PLOS Onehttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0263087
Although MPS and fibromyalgia are defined as separate entities, the two may co-exist or considerably overlap. […] The marked dissociation between the estimated prevalence and burden of MPS, and the length of text on it in common medical textbooks, reflects this lack of understanding. […] Studies of fibromyalgia reveal odd findings e.g., complete resolution after laparoscopic surgery, and strong overlap with other conditions (e.g., hypermobility syndrome). […] This scoping review focuses on the organic mechanical aspects of myofascial pain with the hope it might advance our understanding of MPS and fibromyalgia, highlight gaps in current knowledge, and stimulate research in a less explored field. […] The discussion is divided into two parts: part 1 focuses on MPS and suggests a theoretical mechanism (fascial armoring), part 2 discusses empirical evidence in support of fibromyalgia as an entity driven by myofibroblast-generated-tensegrity-tension, as predicted by this model.
- #48 Scoping Review and Interpretation of Myofascial Pain/Fibromyalgia Syndrome: An Attempt to Assemble a Medical Puzzle | medRxivhttps://www.medrxiv.org/content/10.1101/2021.07.06.21260111v2.full-text
Myofascial Pain Syndrome (MPS) is a common overlooked and underdiagnosed condition. […] MPS can evolve into fibromyalgia, and many studies focus on central mechanisms. […] A fundamental difficulty arises when there is no clear definition, epidemiology, pathophysiology, or diagnosis of MPS. […] Estimates are 37 to 65 percent of the population have myofascial pain, which costs the united states $47 billion every year. […] MPS is one the most frequently under-diagnosed, under-treated and misunderstood sources of the ubiquitous aches and pains of humankind. […] Although MPS and fibromyalgia are defined as separate entities, the two may co-exist or considerably overlap. […] In some patients, regionally localized MPS may seem to evolve into fibromyalgia. […] The marked dissociation between the estimated prevalence and burden of MPS, and the length of text on it in common medical textbooks, reflects this lack of understanding.
- #49 Scoping Review and Interpretation of Myofascial Pain/Fibromyalgia Syndrome: An Attempt to Assemble a Medical Puzzle | medRxivhttps://www.medrxiv.org/content/10.1101/2021.07.06.21260111v2.full-text
Myofascial Pain Syndrome (MPS) is a common overlooked and underdiagnosed condition. […] MPS can evolve into fibromyalgia, and many studies focus on central mechanisms. […] A fundamental difficulty arises when there is no clear definition, epidemiology, pathophysiology, or diagnosis of MPS. […] Estimates are 37 to 65 percent of the population have myofascial pain, which costs the united states $47 billion every year. […] MPS is one the most frequently under-diagnosed, under-treated and misunderstood sources of the ubiquitous aches and pains of humankind. […] Although MPS and fibromyalgia are defined as separate entities, the two may co-exist or considerably overlap. […] In some patients, regionally localized MPS may seem to evolve into fibromyalgia. […] The marked dissociation between the estimated prevalence and burden of MPS, and the length of text on it in common medical textbooks, reflects this lack of understanding.
- #50 Scoping review and interpretation of myofascial pain/fibromyalgia syndrome: An attempt to assemble a medical puzzle | PLOS Onehttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0263087
Myofascial Pain Syndrome (MPS) is a common, overlooked, and underdiagnosed condition and has significant burden. MPS is often dismissed by clinicians while patients remain in pain for years. MPS can evolve into fibromyalgia, however, effective treatments for both are lacking due to absence of a clear mechanism. […] A fundamental difficulty arises when there is no clear definition, epidemiology, pathophysiology, or diagnosis of MPS. Having no accepted definition or criteria, clearly raises issues for both diagnosis and potential studies. […] Literature estimates 45% of men and 54% of women in the general population have TrPs. Estimates are 37 to 65 percent of the population have myofascial pain, which costs the united states $47 billion every year. MPS is one the most frequently under-diagnosed, under-treated and misunderstood sources of the ubiquitous aches and pains of humankind.
- #51 Scoping review and interpretation of myofascial pain/fibromyalgia syndrome: An attempt to assemble a medical puzzle | PLOS Onehttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0263087
Although MPS and fibromyalgia are defined as separate entities, the two may co-exist or considerably overlap. […] The marked dissociation between the estimated prevalence and burden of MPS, and the length of text on it in common medical textbooks, reflects this lack of understanding. […] Studies of fibromyalgia reveal odd findings e.g., complete resolution after laparoscopic surgery, and strong overlap with other conditions (e.g., hypermobility syndrome). […] This scoping review focuses on the organic mechanical aspects of myofascial pain with the hope it might advance our understanding of MPS and fibromyalgia, highlight gaps in current knowledge, and stimulate research in a less explored field. […] The discussion is divided into two parts: part 1 focuses on MPS and suggests a theoretical mechanism (fascial armoring), part 2 discusses empirical evidence in support of fibromyalgia as an entity driven by myofibroblast-generated-tensegrity-tension, as predicted by this model.
- #52 Scoping Review and Interpretation of Myofascial Pain/Fibromyalgia Syndrome: An Attempt to Assemble a Medical Puzzle | medRxivhttps://www.medrxiv.org/content/10.1101/2021.07.06.21260111v2.full-text
Myofascial Pain Syndrome (MPS) is a common overlooked and underdiagnosed condition. […] MPS can evolve into fibromyalgia, and many studies focus on central mechanisms. […] A fundamental difficulty arises when there is no clear definition, epidemiology, pathophysiology, or diagnosis of MPS. […] Estimates are 37 to 65 percent of the population have myofascial pain, which costs the united states $47 billion every year. […] MPS is one the most frequently under-diagnosed, under-treated and misunderstood sources of the ubiquitous aches and pains of humankind. […] Although MPS and fibromyalgia are defined as separate entities, the two may co-exist or considerably overlap. […] In some patients, regionally localized MPS may seem to evolve into fibromyalgia. […] The marked dissociation between the estimated prevalence and burden of MPS, and the length of text on it in common medical textbooks, reflects this lack of understanding.
- #53 Myofascial Pain – StatPearls – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/NBK535344/
The prevalence of myofascial pain syndrome in the United States is about 9 million, and it is estimated that the same percentage of patients is found in Canada. Myofascial pain syndrome affects men and women equally, while it is more prevalent in people greater than 60 years of age. There is no convincing data to suggest a relationship between myofascial pain and ethnicity or geographical location.[13] […] Myofascial pain syndrome is a disease with no standard management and surveillance protocol. […] Multiple TPs persistent for not less than a year confirms myofascial pain syndrome.[7]
- #54https://experts.mcmaster.ca/display/publication3560206
Myofascial pain syndrome (MPS) is a chronic regional pain condition characterized by trigger points-hyperirritable spots within taut bands of muscle fibers that cause both localized and referred pain. […] The pathogenesis, diagnostic criteria, and classification of MPS are still under investigation, which complicates the development of standardized treatment protocols. […] Although diagnostic tools have improved, MPS often remains underrecognized due to symptom overlap with other pain disorders, such as fibromyalgia, neuropathic pain, and joint disorders. […] Factors contributing to its onset and persistence include muscle overuse, postural imbalance, systemic conditions, and psychological and behavioral influences. […] This narrative review explores the primary risk factors, current hypotheses on pathogenesis, diagnosis and differential diagnosis, and both conventional and emerging treatments.
- #55 Myofascial Pain Syndrome – Epidemiology Forecast – 2032https://www.researchandmarkets.com/reports/5525418/myofascial-pain-syndrome-epidemiology?srsltid=AfmBOorzogbeYUxun-yPyOmBK7BcJvE2pOBPYGWQ697orOKeNQZ33MMw
This „Myofascial Pain Syndrome – Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted Myofascial Pain Syndrome epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. […] The Myofascial Pain Syndrome epidemiology report gives a thorough understanding of the Myofascial Pain Syndrome by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. […] The Myofascial Pain Syndrome epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. […] The Myofascial Pain Syndrome epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032.
- #56 Myofascial Pain Syndrome – Epidemiology Forecast – 2032https://www.researchandmarkets.com/reports/5525418/myofascial-pain-syndrome-epidemiology?srsltid=AfmBOorzogbeYUxun-yPyOmBK7BcJvE2pOBPYGWQ697orOKeNQZ33MMw
The Myofascial Pain Syndrome epidemiology covered in the report provides historical as well as forecasted Myofascial Pain Syndrome epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032. […] The report provides insight into the historical and forecasted patient pool of Myofascial Pain Syndrome in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan. […] The report assesses the disease risk and burden and highlights the unmet needs of Myofascial Pain Syndrome. […] The Myofascial Pain Syndrome Epidemiology report will allow the user to develop business strategies by understanding the trends shaping and driving the global Myofascial Pain Syndrome market. […] What are the key findings pertaining to the Myofascial Pain Syndrome epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2019-2032)? […] What is the disease risk, burden and unmet needs of Myofascial Pain Syndrome?
- #57 Myofascial Pain Syndromes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034https://www.researchandmarkets.com/reports/5969943/myofascial-pain-syndromes-market-epidemiology?srsltid=AfmBOorKfwHSpRASY5IoZZ-IHP0t0AC0xGRgLDcUGmzhoFjnUecHfMhM
The myofascial pain syndromes market has been comprehensively analyzed in this report titled „Myofascial Pain Syndromes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034”. […] The increasing cases of muscle imbalances due to several factors, such as muscle weakness, tightness, altered movement patterns, etc., leading to the development of trigger points, are primarily driving the myofascial pain syndromes market. […] This report provides an exhaustive analysis of the myofascial pain syndromes market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. […] According to the report the United States has the largest patient pool for myofascial pain syndromes and also represents the largest market for its treatment.
- #58 Myofascial Pain Syndromes Market Size, Trends, Report 2034https://www.imarcgroup.com/myofascial-pain-syndromes-market
According to the report the United States has the largest patient pool for myofascial pain syndromes and also represents the largest market for its treatment. […] What is the number of prevalent cases (2019-2035) of myofascial pain syndromes across the seven major markets? […] What is the size of the myofascial pain syndromes patient pool (2019-2024) across the seven major markets? […] What would be the forecasted patient pool (2025-2035) across the seven major markets? […] What are the key factors driving the epidemiological trend of myofascial pain syndromes? […] What will be the growth rate of patients across the seven major markets?
- #59 Myofascial Pain Syndromes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034https://www.researchandmarkets.com/reports/5969943/myofascial-pain-syndromes-market-epidemiology?srsltid=AfmBOorKfwHSpRASY5IoZZ-IHP0t0AC0xGRgLDcUGmzhoFjnUecHfMhM
The myofascial pain syndromes market has been comprehensively analyzed in this report titled „Myofascial Pain Syndromes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034”. […] The increasing cases of muscle imbalances due to several factors, such as muscle weakness, tightness, altered movement patterns, etc., leading to the development of trigger points, are primarily driving the myofascial pain syndromes market. […] This report provides an exhaustive analysis of the myofascial pain syndromes market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. […] According to the report the United States has the largest patient pool for myofascial pain syndromes and also represents the largest market for its treatment.
- #60 Top Published Expert Doctors for Myofascial Pain Syndromeshttps://findexpertmd.com/d/Myofascial_Pain_Syndromes
337 top medical experts on Myofascial Pain Syndromes across 50 countries and 36 U.S. states, including 176 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants. […] Clinical Trials ClinicalTrials.gov: at least 878 including 21 Active, 578 Completed, 92 Recruiting.
- #61 Myofascial Pain Syndrome: A Nociceptive Condition Comorbid with Neuropathic or Nociplastic Painhttps://www.mdpi.com/2075-1729/13/3/694
Myofascial pain syndrome is a condition characterized by the presence of myofascial trigger points (TrPs) and is a commonly overlooked and ignored cause of musculoskeletal pain. […] Articles about myofascial trigger points have increased in number significantly over the past decade. […] The current paper summarizes data supporting the subgrouping of patients with myofascial TrP pain into nociceptive, nociplastic, or mixed-type phenotype. […] Simple myofascial pain syndrome caused by TrPs is primarily a nociceptive condition, is unlikely to be classified as neuropathic or nociplastic, but can be present in patients as a comorbid condition along with predominantly neuropathic or nociplastic pain syndromes. […] The presence of underlying painful nociplastic comorbidities may lower the threshold for pain by increasing the central nervous system gain, leading to sensitization, and hence TrPs may become a painful generator of pain.
- #62https://experts.mcmaster.ca/display/publication3560206
Myofascial pain syndrome (MPS) is a chronic regional pain condition characterized by trigger points-hyperirritable spots within taut bands of muscle fibers that cause both localized and referred pain. […] The pathogenesis, diagnostic criteria, and classification of MPS are still under investigation, which complicates the development of standardized treatment protocols. […] Although diagnostic tools have improved, MPS often remains underrecognized due to symptom overlap with other pain disorders, such as fibromyalgia, neuropathic pain, and joint disorders. […] Factors contributing to its onset and persistence include muscle overuse, postural imbalance, systemic conditions, and psychological and behavioral influences. […] This narrative review explores the primary risk factors, current hypotheses on pathogenesis, diagnosis and differential diagnosis, and both conventional and emerging treatments.
- #63 Myofascial Pain Syndrome. Epidemiology, Pathophysiology, Diagnosis and Treatmenthttps://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=43909
Myofascial pain syndrome is defined by the presence of myofascial trigger points in a palpable taut band that produces pain and tenderness in the muscle or its fascia. […] In Mexico it is an underdiagnosed disease despite has a high prevalence. This paper reviews the epidemiology, pathophysiology, diagnosis and treatment of myofascial pain syndrome.
- #64 Myofascial Pain Syndrome – WikiSM (Sports Medicine Wiki)https://wikism.org/Myofascial_Pain_Syndrome
Not well described in the literature. […] One study estimated 30% of patients with musculoskeletal complaints suffered from MPS. […] Average age range is typically 27-50 years.
- #65https://experts.mcmaster.ca/display/publication3560206
Myofascial pain syndrome (MPS) is a chronic regional pain condition characterized by trigger points-hyperirritable spots within taut bands of muscle fibers that cause both localized and referred pain. […] The pathogenesis, diagnostic criteria, and classification of MPS are still under investigation, which complicates the development of standardized treatment protocols. […] Although diagnostic tools have improved, MPS often remains underrecognized due to symptom overlap with other pain disorders, such as fibromyalgia, neuropathic pain, and joint disorders. […] Factors contributing to its onset and persistence include muscle overuse, postural imbalance, systemic conditions, and psychological and behavioral influences. […] This narrative review explores the primary risk factors, current hypotheses on pathogenesis, diagnosis and differential diagnosis, and both conventional and emerging treatments.
- #66 Dipòsit Digital de la Universitat de Barcelona: Myofascial pain syndrome associated with trigger points: A literature review. (I): Epidemiology, clinical treatment and etiopathogenyhttps://diposit.ub.edu/dspace/handle/2445/49849
Over the last few decades, advances have been made in the understanding of myofascial pain syndrome epidemiology, clinical characteristics and aetiopathogenesis, but many unknowns remain. […] An integrated hypothesis has provided a greater understanding of the physiopathology of trigger points, which may allow the development of new diagnostic, and above all, therapeutic methods, as well as the establishment of prevention policies and protocols by the health profession. […] Nevertheless, randomized studies are needed to provide a better understanding and detection of the different factors involved in the origin of trigger points.
- #67https://europepmc.org/books/n/statpearls/article-25476/?extid=29261915&src=med
The exact prevalence of myofascial pain syndrome in the general population is rarely mentioned in the existing literature, likely due to the lack of standardized diagnostic criteria. Sources claim that myofascial pain syndrome affects from 30% to 93% of patients seeking care for musculoskeletal pain. Although typically found in the population aged from 27 to 50, the disorder can also affect older and high-risk populations, such as those with sedentary lifestyles, athletes, or workers who have physically demanding jobs. The most frequently affected areas include the neck, shoulders, and back. The gender difference in the incidence of myofascial pain syndrome remains unclear.
- #68 Myofascial Pain | PM&R KnowledgeNowhttps://now.aapmr.org/myofascial-pain/
Myofascial pain is a purely clinical diagnosis and lacks objective and systematic diagnostic criteria. This lack of consensus-driven, reliable diagnostic criteria makes it difficult to establish accurate statistics about incidence and prevalence. Approximately 9 million people in the United States are thought to suffer from myofascial pain. MPS affects up to 95% of patients with chronic pain, and in one study, MPS was found to be the primary cause of pain in 85% of patients attending a large pain center. […] Occupational risk factors for development of MPS include repetitive work activities, sub-optimal ergonomics, and work environments that result in both visual and postural stress.
- #69 Scoping review and interpretation of myofascial pain/fibromyalgia syndrome: An attempt to assemble a medical puzzle | PLOS Onehttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0263087
Myofascial Pain Syndrome (MPS) is a common, overlooked, and underdiagnosed condition and has significant burden. MPS is often dismissed by clinicians while patients remain in pain for years. MPS can evolve into fibromyalgia, however, effective treatments for both are lacking due to absence of a clear mechanism. […] A fundamental difficulty arises when there is no clear definition, epidemiology, pathophysiology, or diagnosis of MPS. Having no accepted definition or criteria, clearly raises issues for both diagnosis and potential studies. […] Literature estimates 45% of men and 54% of women in the general population have TrPs. Estimates are 37 to 65 percent of the population have myofascial pain, which costs the united states $47 billion every year. MPS is one the most frequently under-diagnosed, under-treated and misunderstood sources of the ubiquitous aches and pains of humankind.
- #70 Scoping Review and Interpretation of Myofascial Pain/Fibromyalgia Syndrome: An Attempt to Assemble a Medical Puzzle | medRxivhttps://www.medrxiv.org/content/10.1101/2021.07.06.21260111v2.full-text
Myofascial Pain Syndrome (MPS) is a common overlooked and underdiagnosed condition. […] MPS can evolve into fibromyalgia, and many studies focus on central mechanisms. […] A fundamental difficulty arises when there is no clear definition, epidemiology, pathophysiology, or diagnosis of MPS. […] Estimates are 37 to 65 percent of the population have myofascial pain, which costs the united states $47 billion every year. […] MPS is one the most frequently under-diagnosed, under-treated and misunderstood sources of the ubiquitous aches and pains of humankind. […] Although MPS and fibromyalgia are defined as separate entities, the two may co-exist or considerably overlap. […] In some patients, regionally localized MPS may seem to evolve into fibromyalgia. […] The marked dissociation between the estimated prevalence and burden of MPS, and the length of text on it in common medical textbooks, reflects this lack of understanding.
- #71 Myofascial Pain Syndrome and Trigger-Point Management | Regional Anesthesia & Pain Medicinehttps://rapm.bmj.com/content/22/1/89
Myofascial pain syndrome (MPS) is a common condition often resulting in referral to a pain clinic. The incidence of MPS with associated trigger points appears to vary between 30 and 85% of people presenting to pain clinics, and the condition is more prevalent in women than in men. Patients complain of regional persistent pain, ranging in intensity and most frequently found in the head, neck, shoulders, extremities, and low back. […] A multidisciplinary approach to treatment appears to be most beneficial and may include such modalities as trigger-point injections, dry needling, stretch and spray, and transcutaneous electrical nerve stimulation. […] The definitive pathogenesis of MPS is currently unknown, and no single diagnostic method is consistently positive.
- #72 Myofascial Pain Syndrome: What It Is, Symptoms & Treatmenthttps://my.clevelandclinic.org/health/diseases/12054-myofascial-pain-syndrome
Myofascial pain syndrome is common. Experts estimate that up to 85% of the general population will develop the condition at some point. […] Myofascial pain syndrome is often underdiagnosed and overlooked. This is because many of its symptoms overlap with other conditions that affect your nerves, bones, ligaments or tendons. […] To diagnose myofascial pain syndrome, your healthcare provider will need to physically examine your muscles to feel for taut bands of muscles and then find the tender spots. Finding and applying pressure to a trigger point will result in pain, felt at the immediate spot or in an area a short distance away (referred pain). […] You cant always prevent myofascial pain syndrome. But there are certain things you can do to reduce your risk: Maintain proper sleep hygiene. Reduce your stress. Get exercise.
- #73 Expert consensus on the diagnosis and treatment of myofascial pain syndromehttps://www.wjgnet.com/2307-8960/full/v9/i9/2077.htm
Myofascial pain syndrome (MPS) is characterized by myofascial trigger points and fascial constrictions. […] At present, domestic and foreign scholars have not reached a consensus on the etiology and pathogenesis of MPS. […] Due to the lack of specific laboratory indicators and imaging evidence, there is no unified diagnostic criteria for MPS, making it easy to confuse with other diseases. […] MPS is a common disease that can be seen at any age, though mostly in elderly adults, athletes, hard physical laborers and sedentary workers. […] About 30.0% to 93.0% of patients with musculoskeletal pain suffer from MPS. […] About 46.1% of the patients reveal active MTrP in the physical examinations. […] Clinical studies have shown that at least 40.0% of skeletal muscle pain syndrome is mainly because of the activated trigger points in painful muscles.
- #74 Scoping review and interpretation of myofascial pain/fibromyalgia syndrome: An attempt to assemble a medical puzzle | PLOS Onehttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0263087
Myofascial Pain Syndrome (MPS) is a common, overlooked, and underdiagnosed condition and has significant burden. MPS is often dismissed by clinicians while patients remain in pain for years. MPS can evolve into fibromyalgia, however, effective treatments for both are lacking due to absence of a clear mechanism. […] A fundamental difficulty arises when there is no clear definition, epidemiology, pathophysiology, or diagnosis of MPS. Having no accepted definition or criteria, clearly raises issues for both diagnosis and potential studies. […] Literature estimates 45% of men and 54% of women in the general population have TrPs. Estimates are 37 to 65 percent of the population have myofascial pain, which costs the united states $47 billion every year. MPS is one the most frequently under-diagnosed, under-treated and misunderstood sources of the ubiquitous aches and pains of humankind.
- #75 Scoping Review and Interpretation of Myofascial Pain/Fibromyalgia Syndrome: An Attempt to Assemble a Medical Puzzle | medRxivhttps://www.medrxiv.org/content/10.1101/2021.07.06.21260111v2.full-text
Myofascial Pain Syndrome (MPS) is a common overlooked and underdiagnosed condition. […] MPS can evolve into fibromyalgia, and many studies focus on central mechanisms. […] A fundamental difficulty arises when there is no clear definition, epidemiology, pathophysiology, or diagnosis of MPS. […] Estimates are 37 to 65 percent of the population have myofascial pain, which costs the united states $47 billion every year. […] MPS is one the most frequently under-diagnosed, under-treated and misunderstood sources of the ubiquitous aches and pains of humankind. […] Although MPS and fibromyalgia are defined as separate entities, the two may co-exist or considerably overlap. […] In some patients, regionally localized MPS may seem to evolve into fibromyalgia. […] The marked dissociation between the estimated prevalence and burden of MPS, and the length of text on it in common medical textbooks, reflects this lack of understanding.